CU Anschutz Department of Pharmacology
@cupharmacology.bsky.social did:plc:yxuvo4hieifcpprffxyxvvfx
Our mission is to advance the field of pharmacology through innovative and impactful research and by training the next generation of scientists at the University of Colorado Anschutz Medical Campus. https://linktr.ee/cupharmacology
Bei Bluesky seit
- Follower
- 134
- Folgt
- 58
- Posts
- 155
- Tage in Ranglisten
- 0
Zusammenfassung
CU Anschutz Department of Pharmacology (@cupharmacology.bsky.social) ist seit 21 November 2024 auf Bluesky. Das Konto hat 134 Follower, folgt 58 Konten und hat 155 Posts veröffentlicht.
Ranglisten-Platzierungen
Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.
Dieses Konto war noch in keiner Tagesrangliste.
Zuletzt gelikte Posts
Öffentliche Likes aus dem Bluesky-Netzwerk.
Thomas Flaig (@tomflaigmd.bsky.social), MD, Vice Chancellor for Research at CU Anschutz, continues to lead global bladder cancer treatment guidelines through his role at NCCN. At the NCCN Annual Conference, he outlined new therapies, research, and practical insights to improve patient care. (1/6)
Post anzeigenKudos to four CCTSI program leaders recognized for excellence in #research, #mentorship, and leadership at @cuanschutz.bsky.social and nationally. We’re proud to work with Drs. Natalie Nokoff, Natalie Serkova, Janine Higgins & Paul MacLean. Congrats! 👏 @kmess44.bsky.social, @CCOS-CTSA.bsky.social
Post anzeigenDendritic arbors provide neuroscience with an ideal opportunity to study how individual neurons interact with their broader circuitry and are the field’s best bet to bridge cellular and systems neuroscience, writes @justinkohare.bsky.social. #neuroskyence www.thetransmitter.org/dendrites/de...
Post anzeigenEndocrine Research Conference: Dr Michael Oliphant presented really cool work on understanding breast cancer development and treatment. @cupharmacology.bsky.social
Post anzeigenInhalt nicht verfügbar
Post anzeigen
Blockierte Konten
Blockierungen sind auf Bluesky öffentlich.
Dieses Konto blockiert niemanden.